Biologics Safety Testing Market by Product (Services, Instruments, Kits & Reagents), Test (Sterility Test, Endotoxin, Bioburden, Cell Line Authentication), Application (Blood Products, Vaccine Development, Stem Cell Research) – 2019 to 2024

$3,850.00$5,850.00

Published on: June 2, 2019
Clear
SKU: GMS810 Category:

OVERVIEW

The market for biologics safety testing is expected to reach USD 6.1 billion by 2024, rising over the forecast period at a CAGR of 11.5%. Growth in the pharmaceutical and biotechnology industries driven by government support in both industries, the positive trend in R&D investment in the life sciences industry and an increase in the number of new drug launches are the main drivers of this market’s growth.

Biologics Safety Testing Market by Product (Services, Instruments, Kits & Reagents), Test (Sterility Test, Endotoxin, Bioburden, Cell Line Authentication), Application (Blood Products, Vaccine Development, Stem Cell Research) - 2019 to 2024 1

Biologics Safety Testing Market by Product (Services, Instruments, Kits & Reagents), Test (Sterility Test, Endotoxin, Bioburden, Cell Line Authentication), Application (Blood Products, Vaccine Development, Stem Cell Research) - 2019 to 2024 2

Biologics Safety Testing Market by Product (Services, Instruments, Kits & Reagents), Test (Sterility Test, Endotoxin, Bioburden, Cell Line Authentication), Application (Blood Products, Vaccine Development, Stem Cell Research) - 2019 to 2024 3

Biologics Safety Testing Market by Product (Services, Instruments, Kits & Reagents), Test (Sterility Test, Endotoxin, Bioburden, Cell Line Authentication), Application (Blood Products, Vaccine Development, Stem Cell Research) - 2019 to 2024 4

Biologics Safety Testing Market by Product (Services, Instruments, Kits & Reagents), Test (Sterility Test, Endotoxin, Bioburden, Cell Line Authentication), Application (Blood Products, Vaccine Development, Stem Cell Research) - 2019 to 2024 5

Biologics Safety Testing Market by Product (Services, Instruments, Kits & Reagents), Test (Sterility Test, Endotoxin, Bioburden, Cell Line Authentication), Application (Blood Products, Vaccine Development, Stem Cell Research) - 2019 to 2024 6

Biologics Safety Testing Market by Product (Services, Instruments, Kits & Reagents), Test (Sterility Test, Endotoxin, Bioburden, Cell Line Authentication), Application (Blood Products, Vaccine Development, Stem Cell Research) - 2019 to 2024 7

Biologics Safety Testing Market by Product (Services, Instruments, Kits & Reagents), Test (Sterility Test, Endotoxin, Bioburden, Cell Line Authentication), Application (Blood Products, Vaccine Development, Stem Cell Research) - 2019 to 2024 8

TABLE OF CONTENT

1 Global Biologics Safety Testing Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope

2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 Global Biologics Safety Testing Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography

4 Global Biologics Safety Testing Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis

5 Global Biologics Safety Testing Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies

6 Global Biologics Safety Testing Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes

7 Global Biologics Safety Testing Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)

8 Global Biologics Safety Testing Market – By Product & Service (Market Size – &
million/billion)
8.1 Kits & Reagents
8.2 Services
8.3 Instruments

9 Global Biologics Safety Testing Market – By Test Type
9.1 Sterility Tests
9.2 Cell Line Authentication and Characterisation Tests
9.3 Bioburden Tests
9.4 Endotoxin Tests
9.5 Adventitious Agent Detection Tests
9.6 Other

10 Global Biologics Safety Testing Market – By Application
10.1 Vaccine and Therapeutics Development
10.2 Blood and Blood-related Products Testing
10.3 Cellular and Gene Therapy
10.4 Stem Cell Research

11 Global Biologics Safety Testing Market – By Geography (Market Size – & million/billion)
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 U.K
11.3.2 Germany
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia-Pacific
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 South Korea
11.4.5 Rest of APAC
11.5 Rest of the World
11.5.1 South America
11.5.2 Middle East
11.5.3 Africa

12 Global Biologics Safety Testing Market – Entropy
12.1 New product launches
12.2 M&A’s, collaborations, JVs and partnerships

13 Global Biologics Safety Testing Market Company Profile (Key Players)
13.1 Market Share, Company Revenue, Products, M&A, Developments
13.2 Charles River Laboratories International, Inc.
13.3 Merck KGaA
13.4 Lonza Group Ltd.
13.5 Sartorius AG
13.6 Toxikon Corporation
13.7 Wuxi Apptec
13.8 Pace Analytical Services Inc.
13.9 SGS S.A.
13.10 Eurofins Scientific
13.11 Thermo Fisher Scientific Inc.
13.12 Company 11 & more

14 Global Biologics Safety Testing Market – Appendix
14.1 Sources
14.2 Abbreviations